Drosophila tumor suppressor WARTS (Wts) is an evolutionally conserved serine/threonine kinase and participates in a signaling complex that regulates both proliferation and apoptosis to ensure the proper size and shape of the fly. Human counterparts of this complex have been found to be frequently downregulated or mutated in cancers. WARTS, a human homolog of Wts, is also known as tumor suppressor and mitotic regulator, but its molecular implications in tumorigenesis are still obscure. Here, we show that WARTS binds via its C-terminus to the PDZ domain of a proapoptotic serine protease Omi/ HtrA2. Depletion of WARTS inhibited Omi/HtrA2-mediated cell death, whereas overexpression of WARTS promoted this process. Furthermore, WARTS can enhance the protease activity of Omi/HtrA2 both in vivo and in vitro. Activation of Omi/HtrA2-mediated cell death is thus a potential mechanism for the tumor suppressive activity of WARTS.
Introduction
Cell proliferation and apoptosis are precisely coordinated to form proper shape and size of organs during metazoan development (Conlon and Raff, 1999) . Loss of this coordination leads not only to developmental abnormalities but also to tumorigenesis (Abrams, 2002; Green and Evan, 2002) . A recent screen of Drosophila mutants that result in tissue overgrowth and larger organs identified several genes such as warts (wts), salvador (sav) and hippo (hpo) (Tapon et al., 2002; Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) . Importantly, recent findings provide evidence that mammalian counterparts of these genes involving the size checkpoint network function are tumor suppressors. For instance, mice deficient in mammalian ortholog of wts (also known as lats) develop malignant tumors , and a human homolog of Wts, WARTS, is downregulated or mutated in the subset of human soft-tissue sarcomas (Hisaoka et al., 2002) . Furthermore, the human ortholog of sav, WW45, is mutated in several cancer cell lines (Tapon et al., 2002) .
Drosophila wts, sav and hpo are genetically linked, and the encoded proteins are likely to function as a complex (Tapon et al., 2002; Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) . Wts physically interacts with the WW domain of Sav, and the interaction of Wts with Sav facilitates its phosphorylation by Hpo. Dysfunction of this complex results in accelerated proliferation and defective apoptosis, which are linked to an irregular control of both cyclin E and Drosophila inhibitor of apoptosis protein (DIAP) . Although all three mutants show similar overgrowth phenotypes, null wts mutant has the most severe outcome, suggesting that Wts is the key player of this pathway (Wu et al., 2003) . Therefore, it can be speculated that the downstream targets of Wts play an important role in the regulation of cell proliferation and cell death.
WARTS is a serine-threonine kinase that shares a high degree of sequence homology with members of the myotonic dystrophy protein kinase (DMPK) family (Justice et al., 1995; Xu et al., 1995; Nishiyama et al., 1999; Tao et al., 1999) , many of which participate in mitotic events. We have previously shown that WARTS forms a regulatory complex that includes zyxin, a promoter of actin filament assembly, on the mitotic apparatus, and that it plays a pivotal role in the control of mitotic progression (Hirota et al., 2000) . Recent study has also shown that WARTS is involved in cytokinesis by regulating actin polymerization (Yang et al., 2004) . Furthermore, the expression of a kinase-inactive form of WARTS induced mitotic aberration followed by tetraploidization (Iida et al., 2004) . We thus proposed that WARTS contributes to normal cell division processes and to chromosome stability. However, regulation of mitosis alone is not sufficient to explain the role of WARTS in tumor suppression.
We now show that WARTS interacts with the mitochondrial serine protease Omi (also called HtrA2) that has a similar function to Drosophila proapoptotic proteins Reaper, Hid, Grim and Sickle (Srinivasula et al., 2001; Salvesen and Duckett, 2002) . Omi was previously identified to be released into the cytosol by apoptotic stimuli and induced cell death through its own serine protease activity as well as attenuating the activity of IAPs (inhibitor of apoptosis proteins) (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002; Verhagen et al., 2002) . We found that the C-terminal region of WARTS binds directly to the PDZ domain of Omi and that interaction of WARTS enhances the protease activity of the latter, leading to induction of Omimediated cell death. Our observations indicate that the dual role of WARTS in cell cycle and apoptosis is conserved from invertebrate to vertebrate, and imply that loss of its coordinate regulation promotes mammalian tumor formation.
Results

WARTS binds to the PDZ domain of Omi
To identify proteins that physically interact with WARTS, we screened a HeLa cell cDNA library with the use of the yeast two-hybrid system. We used the Cterminal region of human WARTS (designated as the SS fragment; Figure 1a ) as the bait for the screen because of its low homology to another human homolog of Wts, LATS2, and to other DMPK family proteins. Identification of molecules that interact with this portion of WARTS might thus be expected to provide clues to the specific functions of this protein. This screening yielded eight independent but overlapping cDNA clones derived from the same gene, that for Omi/HtrA2 (Figure 1a ).
To verify that Omi interacts directly with WARTS, we first performed an in vitro binding assay with a glutathione S-transferase (GST) fusion protein containing the Omi/PDZ-encoded fragment (C70; the smallest cDNA obtained during the screening; Figure 1a ) (amino acids 354-458). We also used GST fusion proteins containing either the PDZ domains of NE-dlg or fulllength PSD95 (postsynaptic density 95) as controls to confirm the specificity of an interaction between the PDZ domain of Omi and WARTS. Full-length WARTS was co-precipitated with GST-Omi/PDZ(C70) but not with GST-NE-dlg/PDZ, GST-PSD95 or GST alone (Figure 1b , left panels). To examine whether the PDZ domain of Omi was exclusively responsible for the interaction with WARTS, we incubated GST fusion proteins containing either full-length Omi or an Omi mutant lacking the PDZ domain (DPDZ) with fulllength WARTS. Whereas GST-Omi bound to WARTS, GST-Omi(DPDZ) did not ( Figure 1c) . Furthermore, the interaction between Omi and the C-terminal half of WARTS(DN2) (residues 481-1130) was found to be impaired when Omi had a mutation in the PDZ domain (Y361A) (Supplementary Figure S1) . These results thus indicated that the interaction of WARTS with Omi is specific and is mediated exclusively by the PDZ domain of Omi.
The sequence DLVYV present at the C-terminus of WARTS displays similarity to the consensus motif for a PDZ binding domain. We therefore examined whether this C-terminal sequence of WARTS is required for the interaction with Omi. The in vitro binding assay revealed that neither WARTS(DN1-DVYV) (amino acids 705-1127) nor WARTS(DN1-DSS) (residues 705-1110) bound to GST-Omi/PDZ, whereas WARTS(DN1) (residues 705-1130) did (Figure 1a and d) , indicating that the sequence VYV at the C-terminus of WARTS is required for the interaction with Omi. As an additional control, we showed that the C-terminus of APC (adenomatous polyposis coli), which is known to bind to a PDZ domain of NE-dlg (Makino et al., 1997) , was Specific interaction between Omi and WARTS in vitro. Recombinant full-length WARTS produced in insect cells was incubated with either GST alone, GST-Omi/PDZ(C70), GST-PDZ(NE-dlg) (residues 128-490 of NE-dlg) or GST-PSD95, each bound to glutathioneagarose beads. The bead-bound proteins (as well as the WARTS input to the binding reaction) were then subjected to immunoblot analysis with antibodies to WARTS (C2) or to GST (left panels). Alternatively, lysates of COS-7 cells expressing a C-terminal portion of human APC (residues 2713-2843) tagged at its NH 2 -terminus with the Myc epitope were incubated with purified GST, GST-Omi/ PDZ(C70) or GST-PDZ(NE-dlg) coupled to glutathione-agarose. The bead-bound proteins were then subjected to immunoblot analysis with antibodies to Myc (9E10) or to GST (right panels). (c) Role of the PDZ domain of Omi in the interaction with WARTS in vitro. Purified full-length WARTS was incubated with GST fusion proteins of full-length Omi or of Omi(DPDZ) (lacking residues 386-445) coupled to glutathione-agarose, after which bead-bound proteins were subjected to immunoblot analysis with antibodies to WARTS or to GST. (d) Role of the C-terminus of WARTS in the interaction with Omi in vitro. Lysates of COS-7 cells expressing HAtagged DN1, DN1-DVYV or DN1-DSS mutants of WARTS were incubated with GST or GST-Omi/PDZ(C70) coupled to glutathioneagarose, after which bead-bound proteins (as well as cell lysates) were subjected to immunoblot analysis with antibodies to HA. (e) Interaction of the mature form of endogenous Omi with endogenous WARTS in HeLa cells. Cell lysates were subjected to immunoprecipitation with control immunoglobulin G or antibodies to WARTS (C2), and the resulting precipitates were subjected to immunoblot analysis with antibodies to Omi (RC70). Immunoblotting of whole-cell lysate with RC70 antibody is shown in the left lane. (f) Role of the three C-terminal amino acids of WARTS in the interaction with endogenous Omi. Lysates of HEK293 cells expressing HA-tagged full-length WARTS or HA-WARTS(DVYV) were subjected to immunoprecipitation with antibodies to HA, and the resulting precipitates were subjected to immunoblot analysis with antibodies to Omi (RC70) or to HA not precipitated with GST-Omi/PDZ (Figure 1b , right panels), demonstrating the specificity of the interaction between the C-terminus of WARTS and the PDZ domain of Omi.
To determine whether WARTS interacts physically with Omi in living mammalian cells, we prepared affinity-purified rat antibodies to Omi (designated RC70). It was previously reported that the precursor form of Omi is a 50-kDa protein whose N-terminal region is removed to generate the 36-kDa mature protein (catalytically active) in mitochondria (Gray et al., 2000) . Figure S2) . By using the RC70 antibody, we found that most of the endogenous Omi exist as a mature form in HeLa cells and that the endogenous mature Omi was co-precipitated with endogenous WARTS (Figure 1e ), indicating that the two proteins interact in vivo. We next expressed full-length WARTS or the C-terminally truncated mutant WARTS(DVYV) as hemagglutinin epitope (HA)-tagged proteins in HEK293 cells and subjected cell lysates to immunoprecipitation with antibodies to HA. Endogenous Omi was detected in the immunoprecipitates containing full-length WARTS, but not in those containing WARTS(DVYV) (Figure 1f ), further confirming that the C-terminus of WARTS is essential for interaction with Omi in vivo.
WARTS plays a role in Omi-mediated cell death
It has been reported that staurosporine (STS) induces the translocation of mature Omi from mitochondria to the cytosol and potentiates cell death in HeLa cells (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002; Verhagen et al., 2002) . The released mature Omi binds to and blocks the activity of IAPs, leading to the activation of caspases and execution of cell death. In addition to this caspase-dependent pathway, the cytosolic mature Omi can induce cell death through its own protease activity even when caspases are inactivated (Suzuki et al., 2001; Hegde et al., 2002; Verhagen et al., 2002) . To assess the role of Omi in STS-induced cell death, we depleted the expression of endogenous Omi in HeLa cells by transfection with a small interfering RNA (siRNA) specific for Omi mRNA (Supplementary Figure S3 ). Cells depleted of Omi exhibited an increased resistance to STS-induced cell death compared with cells transfected with a control siRNA ( Figure 2a ). In this condition, several other factors, such as cytochrome c and Smac/DIABLO, released from the mitochondria together with Omi also activate caspases to lead to cell death (Wang, 2001) . We thus blocked the caspase activity to evaluate specifically the contribution of Omi protease activity on STS-mediated cell death. In the presence of the general caspase inhibitors z-VAD-fmk or Boc-D-fmk (BAF), the number of cells undergoing STSinduced death was 3-7-fold greater for those transfected with the control siRNA than for those transfected with the Omi siRNA ( Figure 2a ). The same results were obtained when alternative Omi siRNA (#2) was used (Supplementary Figure S4A) . These findings indicated that the caspase-independent function of Omi protease plays an important role in cell death triggered by STS in HeLa cells. Drosophila Wts has been recently shown to play a critical role in programmed cell death during developmental stages (Tapon et al., 2002; Wu et al., 2003) . However, little is known about whether WARTS participates in the cell death pathway of mammalian cells upon apoptotic stimuli. To address this issue, we suppressed the expression of endogenous WARTS protein in HeLa cells by using a WARTS siRNA ( Figure 2b ). Such a depletion of WARTS significantly suppressed the STS-induced cell death ( Figure 2c ). Moreover, the WARTS depletion resulted in an B75% decrease in the percentage of dead cells apparent after treatment for 12 h with STS in the presence of z-VAD-fmk ( Figure 2c ). The same outcome was observed when alternative WARTS siRNA was used (Supplementary Figure S4B) . Given that Omi is heavily involved in STS-induced cell death (Figure 2a ), WARTS can be associated with the Omi-mediated pathways. It has been previously reported that UV-induced cell death is inhibited by Omi depletion (Martins et al., 2002) . Similarly, depletion of WARTS by siRNAs also markedly inhibited UV-induced HeLa cell death in the presence of z-VAD-fmk ( Figure 2d , Supplementary Figure S4C ). These results, together with the finding that WARTS interacts with Omi, led us to speculate that WARTS is involved in the Omi-mediated cell death pathways.
Given that WARTS plays a role in mitotic progression (Hirota et al., 2000) , it was possible that inhibition of cell death might be caused by an alteration of cell cycle status by depletion of WARTS. Flow cytometric analysis revealed that the cell cycle distribution of WARTS-depleted HeLa cells induced a slight accumulation of the G2/M population (Figure 2e) , which is possibly due to the small delay of late mitotic phase in the WARTS-deficient cells (Iida et al., 2004) . We therefore compared the susceptibility to STS-induced apoptosis of WARTS-deficient cells and cells depleted of Cdh1, a regulator of the anaphase-promoting complex (Figure 2b ). We previously showed that loss of Cdh1 results in a slight delay in late mitosis, an effect similar to that of WARTS depletion (Sudo et al., 2001) . Unlike WARTS depletion, Cdh1 depletion did not suppress the STS-induced cell death (Figure 2c) , suggesting that the death-promoting effect of WARTS is not a consequence of its action in cell cycle regulation.
Next, we investigated the role of WARTS in the Omimediated cell death pathway. Expression of the fulllength wild-type WARTS alone did not significantly induce death in HEK293 cells (Figure 2f ; Supplementary Figure S5 ), which is consistent with the observation that the overexpression of Wts does not induce marked cell death in Drosophila ommatidial cells (Tapon et al., 2002; Wu et al., 2003) . However, cell death induced by (Figure 2g ). These results again implicate WARTS's role in Omi-mediated cell death, especially the importance of an interaction of both molecules.
To clarify when and where WARTS contributes to the Omi-mediated cell death pathway, we performed immunocytochemical analysis of WARTS and Omi in cells receiving apoptotic stimuli. Most Omi molecules localize to the intermembrane space of mitochondria under basal conditions, but are released into the cytosol in response to apoptotic stimuli, where WARTS protein abundantly exists (Figure 3a) . Thus, WARTS might become associated with Omi at cytosol upon apoptotic stimuli. Using a subcellular fractionation and subsequent immunoprecipitation assay, we confirmed colocalization and interaction of WARTS and Omi at cytosol in cells that received apoptotic stimulus (Figure 3b ). It is noted that a characteristic punctuate mitochondrial pattern was also detected by an anti-WARTS antibody in untreated cells (Figure 3a) , suggesting that a small fraction of WARTS exits at mitochondria in nonapoptotic cells. However, the significance of this fraction remains unknown.
Interaction of WARTS activates Omi-mediated cell death
There are at least two potential mechanisms by which WARTS might contribute to Omi-mediated cell death: (1) WARTS enhances Omi-mediated inhibition of IAPs to activate caspases. (2) Interaction with WARTS activates Omi protease in a caspase-independent manner. We found that WARTS interacts with Omi and XIAP (X-linked inhibitor of apoptosis protein) in human cells when the full-length Omi was overexpressed ( Figure 4a, lane 2) . This finding indicates that WARTS forms a complex with XIAP while interacting with Omi and is potentially involved in the cell death through the inhibition of XIAP. It has been previously reported that the N-terminus AVPS structure of mature Omi is critical for binding to IAPs (Suzuki et al., 2001; Verhagen et al., 2002) . Therefore, when exogenous mature Omi, which has modified N-terminus (MAVPS), was overexpressed, XIAP could not interact with Omi and WARTS complex (Figure 4a, lane 3) . Importantly, as shown in Figure 2f and g, WARTS can potentiate cell death mediated by the exogenous mature Omi, which has modified N-terminus (MAVPS or GFP-fused at the Nterminus), suggesting that interaction between Omi and XIAP is not the exclusive mechanism for Omi to induce cell death. Furthermore, the IAP binding motif of Omi is not conserved in all mammalian homologs (Li et al., 2002) . These evidences thus suggest that the caspaseindependent pathway is also important for Omimediated cell death. To examine this possibility, we established stable cell lines expressing either a GFP fusion protein containing the 20 C-terminal amino acids of WARTS (GFP-SS) or GFP alone (Supplementary Figure S7) . Cells expressing GFP-SS showed an increased sensitivity to STS-induced death, compared with those expressing GFP alone, after depletion of endogenous WARTS by RNAi (Figure 4b) . Expression of the SS fragment of WARTS fused with GST (GST-SS), in comparison to GST alone, significantly potentiated the induction of cell death by mature Omi (Figure 4c) . Furthermore, an in vitro assay for measuring Omi protease activity, which uses FITC-casein as a substrate, revealed that the GST-SS fragment enhanced the activity of Omi (Figure 4d ). These results support the notion that the C-terminus of WARTS activates Omi-mediated cell death by directly promoting its protease activity.
We further analysed whether STS or UV-induced cell death is due to WARTS-mediated activation of Omi ) in the presence of z-VAD-fmk (50 mM). Cells were fixed after 12 h incubation, and then stained with antibodies to WARTS (C2) and to Omi (RC70). Scale bar, 20 mm. (b) Colocalization and interaction of Omi with WARTS in cytosolic fraction during STS-induced apoptosis. HeLa cells were incubated for 5 h in the absence or presence of STS (1 mM), and cell lysates were subjected to the subcellular fractionation. The cytosolic and mitochondrial fractions were immunoblotted with antibodies to WARTS, to Omi and to cytochrome c (left panels). The cytosolic fractions were subjected to immunoprecipitation assay using antibodies to WARTS (C1), and then the bound proteins were immunoblotted with anti-Omi antibody (RC70) (right panels) WARTS activates Omi-dependent cell death S Kuninaka et al protease. To monitor the activity of Omi protease in living cells, we examined levels of IAPs, which have been recently reported as not only Omi-binding proteins but also as direct substrate of Omi protease during apoptosis Yang et al., 2003; Suzuki et al., 2004) . Consistent with the previous reports, degradation of XIAP was inhibited by depletion of Omi in the STS-treated cells (Figure 5a ), suggesting that Omi protease is activated during apoptosis. Depletion of WARTS effectively prevented XIAP and cIAP1 from being proteolysed by STS and UV irradiation (Figure 5b ). These results strongly suggest that interaction of WARTS promotes protease activity of Omi in vivo.
Finally, we asked whether the kinase activity of WARTS contributes to the Omi-mediated cell death pathway. To address this issue, we first established mouse fibroblasts (NIH3T3) stably expressing the wild or kinase-dead form of human WARTS by retrovirusmediated gene transfer. These cells were transfected with siRNA specific for mouse endogenous WARTS, but not for human WARTS (Figure 6a ). Cells transfected with mouse WARTS siRNA showed a declined expression of endogenous WARTS (lane 4), but an abundance of exogenously expressed human WARTS was not affected by this RNA interference (lanes 5 and 6). We then analysed sensitivity of these cells to UV irradiation. This experiment allowed us to evaluate a role for the FITC-casein (10 mg) was incubated with the recombinant wild-type Omi (100 nM) in the presence of 1 mM GST or GST-SS for the indicated time. The reaction mixtures were then subjected to SDS-PAGE. Proteolysis of FITC-casein visualized using UV illuminator was then analysed WARTS activates Omi-dependent cell death S Kuninaka et al exogenous human WARTS on UV-induced cell death, which was previously reported to be mediated by the Omi signaling pathway (Martins et al., 2002) . We found that cells expressing the kinase-dead WARTS were significantly resistant to UV-induced cell death compared to those expressing the wild-type WARTS (Figure 6b ), suggesting that kinase activity of WARTS is required for Omi-mediated cell death. Immunoprecipitation assay showed that the kinase-dead WARTS failed to interact with Omi in vivo (Figure 6c) , suggesting that the C-terminal region of kinase-dead WARTS may not be exposed for binding to Omi. This is consistent with our conclusion that interaction of Omi with WARTS is required for its protease activity to induce cell death, and further indicates the significance of the kinase activity of WARTS to regulate the Omi-mediated cell death.
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Discussion
WARTS was identified as the human homolog of the Drosophila tumor suppressor Wts (Nishiyama et al., 1999; Tao et al., 1999) . Although WARTS was found to be downregulated or mutated in a subset of human cancers (Hisaoka et al., 2002) , its molecular implications in tumorigenesis remain to be elucidated. We have now shown that the C-terminus of WARTS specifically interacts with the PDZ domain of Omi in the cytoplasm upon apoptotic stimuli and that the interaction promotes a protease activity of Omi, indicating that WARTS is not only a physiological target for the PDZ domain of Omi but also an activator of its protease activity. Activated Omi can induce cell death through its own protease activity and the ability to activate caspase pathways by inhibiting IAPs. Therefore, regulation of cell death through Omi might be an important mechanism for WARTS to act as a tumor suppressor. Drosophila Wts has been reported to regulate cell death through DIAP during the developmental process (Harvey et al., 2003; Udan et al., 2003; Wu et al., 2003) . Wts controls an abundance of DIAP at both transcriptional and translational levels. Consistent with these data found in Drosophila, depletion of WARTS increases IAP protein levels in human cells (Figure 5b) . From the data that activated Omi directly cleaves IAPs Yang et al., 2003; Suzuki et al., 2004) and that WARTS promotes the protease activity of Omi (Figure 4d ), WARTS could regulate the protein level of IAPs through the direct cleavage process. However, there are other regulation mechanisms of abundance of Drosophila DIAP: translational inhibition and/or ubiquitin-mediated protein degradation stimulated by Reaper, Hid and Grim (Holley et al., 2002; Ryoo et al., 2002; Yoo et al., 2002) . It was previously found that XIAP has ubiquitin , and then cultured for 9 h in the presence of 20 mM z-VAD-fmk. Cell lysates were subjected to immunoblot analysis using indicated antibodies. Proteolysis of XIAP (left panels) and cIAP1 (right panels), both are known Omi substrates, was inhibited by depletion of WARTS WARTS activates Omi-dependent cell death S Kuninaka et al ligase activity and catalyses its own ubiquitination (Yang et al., 2000) . Therefore, it is possible that WARTS and/or Omi also stimulate degradation of IAPs through activation of the ubiquitin-proteasome pathway. Nonetheless, our data indicate that WARTSmediated targeting of IAPs is conserved throughout evolution and reveal the important link between two novel apoptotic pathways identified in Drosophila, the Warts/Salvador/hippo(Mst) pathway, and the Reaper, Hid and Grim (putative functional homologs of Omi) pathway, in mammalian cells.
We have shown that the interaction with WARTS is required for the activation of Omi protease, which is a critical step for cell death execution. Recent analysis of the crystal structure of Omi (Li et al., 2002) has provided insight into the mechanism of its activation and further supports our proposal that the interaction with WARTS activates Omi protease in the death signaling pathway. Omi forms a pyramid-shaped homotrimer through interaction of the protease domains. The PDZ domain of Omi was shown to be closely associated intramolecularly with the serine protease domain and to restrict access to the active site. On the basis of this structural analysis, the PDZ domain was proposed to serve as a negative regulator of protease activity. Association of a target protein with the PDZ domain might be expected to trigger a conformational change that opens up access to the active site of the protease domain and thereby increases catalytic activity. This model is also supported by the recent observation that a short peptide with the preferred binding sequence of PDZ domain of Omi can lead to the activation of the protease in vitro (Martins et al., 2003) . Omi molecules that translocate from mitochondria to the cytoplasm in response to apoptotic stimuli might thus become associated through their PDZ domains with WARTS, resulting in the induction of protease activity and the consequent execution of cell death.
It has been recently reported that Omi degrades a mitochondrial antiapoptotic protein HAX-1 in the Lysates of HEK293 cells expressing HA-tagged full-length wild-type or kinase-dead mutant of WARTS or HA-WARTS(DVYV) were subjected to immunoprecipitation with antibodies to HA. The resulting precipitates were then subjected to immunoblot analysis with antibodies to Omi (RC70) or to HA mitochondria before it translocates to the cytoplasm, suggesting that Omi is activated inside the mitochondria upon apoptotic stimuli and removes the HAX-1 as an early event in the Omi-mediated apoptotic process . Our findings suggest that WARTS interacts with Omi in the cytoplasm after Omi is released from the mitochondria. Thus, WARTS may act as a critical enhancer of Omi protease, which degrades various substrates such as IAPs in the cytoplasm.
A recent report has shown that the neuromuscular disorders of mnd2 mutant mice result from the proteaseinactive mutation of Omi (Jones et al., 2003) . Neuronal degenerations in this mouse are features of both apoptosis and necrosis. Interestingly, the mnd2 micederived fibroblast increases the susceptibility of mitochondria to induce the permeability transition, resulting in it being vulnerable to stress. Omi is thus regarded as a stress sensor of mitochondria to maintain its homeostasis in a physiological setting. This result seems to contradict many previous reports, including our present study, that the protease activity of Omi can contribute to cell death process (Suzuki et al., 2001; Hegde et al., 2002; Cilenti et al., 2004; Trencia et al., 2004) . This might reflect the cellular localization where Omi protease functions; cytosolic mature wild-type Omi released from mitochondria can function in cell death, whereas Omi mainly serves as a stress sensor in mitochondira. Further studies to analyse correlative interaction between cell death and cell cycle progression will help clarify this complex situation. Omi was found to highly express in some cancer cell lines, yet mutations of the transcripts were not investigated (Faccio et al., 2000) . Thus, the contribution of Omi in tumorigenesis is still largely unknown. Our report, however, implies the possible involvement of Omi in this process.
WARTS is a serine-threonine kinase and its kinase activity plays an important role in mitotic progression (Iida et al., 2004) . Our data indicate that the kinaseinactive mutant of WARTS attenuates its ability to enhance Omi-mediated cell death (Figure 6b ). We also found that kinase activity of WARTS is required for in vivo interaction with Omi (Figure 6c ), further confirming that interaction with Omi is required for WARTS to induce cell death. Although an underlying reason why kinase-dead WARTS fails to interact with Omi is obscure, we speculate that the kinase activity is necessary for exposing the structure of the C-terminal region of WARTS for docking to the PDZ domain of Omi. Such a conformational change of kinase by posttranslational modification is one way to modulate its activity, for example, phosphorylation of the active segment of MAP kinase makes its aC helix proper orientation to organize the C-terminal extension into a homodimerization interface (Huse and Kuriyan, 2002) . Further analyses including structural studies of the active state of WARTS will be required for elucidating this issue. Nonetheless, our data indicate the connective role of WARTS in both mitotic progression and apoptosis.
Dysregulation of programmed cell death has been implicated in tumorigenesis (Cory and Adams, 2002) .
In addition to caspase-mediated apoptosis, programmed cell death can be mediated in a caspase-independent manner (Leist and Jaattela, 2001 ). The activation of mitogenic oncogenes (such as those encoding Myc, E1A or Cdc25) or inactivation of tumor suppressor genes (such as those for Rb or p53) results in a loss of cell cycle regulation, and also promotes cell death (Evan et al., 1995; Schmitt and Lowe, 1999) . Crosstalk between the cell cycle machinery and the cell death program has therefore been suggested to function as a cellular failsafe mechanism to restrain tumor development (Green and Evan, 2002) . We and others have previously revealed that WARTS regulates mitotic progression in human cells and that WARTS dysfunction results in failure of normal mitosis (Hirota et al., 2000; Iida et al., 2004; Yang et al., 2004) . In the present study, we show that WARTS contributes not only to the caspasedependent pathway through interaction with Omi and XIAP but also to the caspase-independent pathway of cell death through its effect on Omi protease activity. Human WARTS, similar to Drosophila WTS, may thus act as a tumor suppressor by controlling both the cell cycle and cell death.
Materials and methods
Yeast two-hybrid screening
Nucleotide oligomers (corresponding to the 20 C-terminal amino acids of human WARTS) were subcloned into pAS2-1c prey vector (kindly provided by T Maeda). CG 1945 yeast cells harboring pAS2-1c/SS were transformed by the lithium acetate method with a HeLa cell cDNA library constructed in pGAD-GH (Clontech). Of the B9.3 Â 10 6 independent clones screened, 6000 were His þ and 540 were positive for b-galactosidase activity. Plasmids harboring cDNAs were recovered from positive colonies and their nucleotide sequences were determined as described (Hirota et al., 2000) .
Cell culture and transfection
HeLa, COS-7, HEK293 or HEK293 T cells were grown under an atmosphere of 5% CO 2 at 371C in Dulbecco's modified Eagle's medium (DMEM)-F12 supplemented with 10% heatinactivated fetal bovine serum without antibiotics. Cells were subjected to transient transfection with the use of Lipofectamine and Plus reagent (Invitrogen) or FuGene6 (Roche). For production of stable cell lines, HeLa cells were cotransfected with pEGFP or pEGFP-WARTS/SS and the puromycin resistance gene; transfectants were selected in the presence of puromycin (2.5 mg/ml) for 7 days and then cloned by limiting dilution. Preparation of retrovirus and infection to NIH3T3 cells were performed as described elsewhere (Morita et al., 2000) .
Plasmids and antibodies
Mammalian expression plasmids for HA-or FLAG-tagged proteins were constructed by subcloning polymerase chain reaction (PCR)-amplified DNA fragments into pCGN or pcDNA3 (Invitrogen), respectively. For expression of GST fusion proteins in bacteria, PCR products were subcloned into pGEX2TH or pGEX4T-1 (Amersham). All PCR products were synthesized with the use of PyroBest DNA polymerase (Takara) and their sequences were confirmed by direct DNA sequencing. Mutations in WARTS or Omi cDNAs were generated in vitro with cloned Pfu DNA polymerase (Stratagene) in the presence of sense and antisense strand-annealing oligonucleotides containing the indicated mutated sequences; they were confirmed by DNA sequencing. Retrovirus expression vector was constructed by inserting a fragment encoding a wild-type or kinase-dead (K734A) mutant of full-length WARTS into the EcoRI/NotI sites in pMXpuro plasmid.
Rabbit polyclonal antibodies to WARTS (C1 and C2) were generated as we described previously (Morisaki et al., 2002) . A GST-WARTS (amino acids 136-700) fusion protein was also used to generate rabbit polyclonal antibodies to WARTS (60-2). Polyclonal antibodies to Omi (RC70) were prepared by injecting rats with hexahistidine-tagged Omi (362-458). Monoclonal antibodies to the FLAG epitope (M2) and to HA (3F10) were obtained from Sigma-Aldrich and Roche, respectively. Other antibodies used in this study included those to GST (Pharmacia), to a-tubulin (B-5-1-2, Sigma-Aldrich), to GFP (FL, Santa Cruz Biotechnology), to Myc (9E10, Santa Cruz Biotechnology), to Cdh1 (DH01, NeoMarkers), to XIAP (Transduction Laboratories, R&D systems) and to c-IAP1 (R&D systems).
GST pull-down assays and immunoprecipitation
For GST 'pull-down' assays, cells transfected with the indicated vectors were washed with phosphate-buffered saline (PBS) and lysed by incubation for 15 min on ice with lysis buffer (0.5% NP-40, 25 mM Tris-Cl (pH 7.5), 137 mM NaCl, 1 mM EDTA, 5% glycerol, 1 mM dithiothreitol, 20 mM b-glycerophosphate, 1 mM sodium vanadate, aprotinin (2 mg/ml), 1 mM 4-(2-aminoethyl)-benzene sulfonyl fluoride hydrochloride, 10 mM leupeptin, 1 mM pepstatin). After centrifugation of the lysate at 14 000 g for 20 min, portions of the supernatant (B800 mg of protein in 400 ml) were incubated for 3 h at 41C with 25 mg of GST or GST-Omi fusion proteins immobilized on glutathione-agarose beads (Sigma). The beads were then separated by centrifugation and washed with lysis buffer, and the bound proteins were eluted by boiling for 5 min in SDS sample buffer and subjected to immunoblot analysis.
RNAi
HeLa cells were seeded in six-well plates at a density of 2 Â 10 4 / well on the day before transfection. They were transfected for 86 h with siRNA duplexes at a final concentration of 200 nM with the use of Oligofectamine (Invitrogen) as described (Elbashir et al., 2001) , after which they were processed for immunoblot analysis or first treated with STS (Sigma), z-VAD-fmk (Enzyme Systems Products), BAF (Alexis Biocehmicals) or UV irradiation. Cell viability was assessed on the basis of trypan blue exclusion. For UV treatment, cells were washed with PBS, irradiated with UV light in PBS, and then incubated in culture medium for 14 h before analysis. The siRNA oligonucleotides were obtained from Japan BioService and had the following sequences: control sense, 5 0 -AGCCAU CUGAUGCCGCAAAdTdT-3 0 ; control antisense, 5 0 -UUU (Brummelkamp et al., 2002) .
Morphological determination of cell death
HEK293 cells were seeded in 35-mm Petri dishes (5 Â 10 5 cells/ dish) the day before transfection with 0.1 mg of pEGFP-F (Harvey et al., 2000) , 0.05 mg of pcDNA3 encoding Cterminally FLAG-tagged mature Omi and 2 mg of pCGN encoding N-terminally HA-tagged WARTS or WARTS(DVYV) (or the empty vector). After 24 h, the cells were fixed and stained with propidium iodide. The percentage of GFPexpressing cells exhibiting morphological characteristics of cell death was determined by examining >300 cells by fluorescence microscopy.
Subcellular fractionation
HeLa cells were treated with the STS (1 mM) for 5 h. Cells were suspended in isotonic buffer (200 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES (pH 6.9) and 1 mM DTT) supplemented with 100 mM AEBSF and 250 mM TLCK, and then homogenized using Dounce homogenizer. Cell lysates were fractionated into a cytosol and mitochondrial fraction as described previously (Tsuruta et al., 2002) .
Flow cytometry
Cell cycle profile was determined as described previously (Sudo et al., 2001) . Annexin-V staining was performed according to the manufacturer's instruction (MBL).
